The translational landscape of mTOR signalling steers cancer initiation and metastasis
Open Access
- 22 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 485 (7396), 55-61
- https://doi.org/10.1038/nature10912
Abstract
The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth and cancer. However, the downstream translationally regulated nodes of gene expression that may direct cancer development are poorly characterized. Using ribosome profiling, we uncover specialized translation of the prostate cancer genome by oncogenic mTOR signalling, revealing a remarkably specific repertoire of genes involved in cell proliferation, metabolism and invasion. We extend these findings by functionally characterizing a class of translationally controlled pro-invasion messenger RNAs that we show direct prostate cancer invasion and metastasis downstream of oncogenic mTOR signalling. Furthermore, we develop a clinically relevant ATP site inhibitor of mTOR, INK128, which reprograms this gene expression signature with therapeutic benefit for prostate cancer metastasis, for which there is presently no cure. Together, these findings extend our understanding of how the ‘cancerous’ translation machinery steers specific cancer cell behaviours, including metastasis, and may be therapeutically targeted.Keywords
This publication has 40 references indexed in Scilit:
- Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblastsBiochemical Journal, 2011
- Vimentin organization modulates the formation of lamellipodiaMolecular Biology of the Cell, 2011
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionProceedings of the National Academy of Sciences of the United States of America, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPsScience, 2010
- Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft StudiesPLOS ONE, 2010
- Isolation, cultivation and characterization of adult murine prostate stem cellsNature Protocols, 2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- Basal epithelial stem cells are efficient targets for prostate cancer initiationProceedings of the National Academy of Sciences of the United States of America, 2010